Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bladder cancer
Closed
Phase 3
This trial is looking at adding a drug called pembrolizumab to chemotherapy and radiotherapy (chemoradiotherapy). It is for people with bladder cancer that has spread into or through the muscle layer of the bladder. This is called muscle invasive bladder cancer, or invasive bladder cancer.
Recruitment start: 17 June 2021
Recruitment end: 20 September 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Ursula McGovern
Merck Sharp & Dohme Ltd
Last reviewed: 21 Jan 2025
CRUK internal database number: 17524